Old Web
English
Sign In
Acemap
>
authorDetail
>
Brian Lian
Brian Lian
Internal medicine
Medicine
Diabetes mellitus
Beta (finance)
Agonist
4
Papers
46
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A liver-specific thyromimetic, VK2809, decreases hepatosteatosis in glycogen storage disease type Ia (GSD Ia)
2019
Thyroid
Jin Zhou
Lauren R. Waskowicz
Andrea Lim
Xiao Hui Liao
Brian Lian
Hiroko Masamune
Samuel Refetoff
Brian Tran
Dwight D. Koeberl
Paul M. Yen
Show All
Source
Cite
Save
Citations (15)
LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial
2019
Journal of Hepatology
Rohit Loomba
Joel Neutel
Rizwana Mohseni
David Bernard
Randall Severance
Michael Dao
Satinder Saini
Carmen Margaritescu
Ken Homer
Brian Tran
Marianne Mancini
Hiroko Masamune
Brian Lian
Show All
Source
Cite
Save
Citations (23)
Abstract 14497: Reduction of Atherogenic Lipoprotein (a) and Apolipoprotein B in Humans With the Selective Thyroid Receptor Beta Agonist Vk2809
2016
Circulation
Steven L Schoenfeld
Brian Lian
Rochelle Hanley
Show All
Source
Cite
Save
Citations (0)
A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE LIVER-SELECTIVE TR-BETA AGONIST VK2809 (MB07811) IN HYPERCHOLESTEROLEMIC SUBJECTS
2016
Journal of the American College of Cardiology
Brian Lian
Rochelle Hanley
Steve Schoenfeld
Show All
Source
Cite
Save
Citations (8)
1